drugset / Trial / NCT01419236

A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

NCT01419236

Phase 2 Completed 76 enrolled Eli Lilly and Company
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to see if testosterone solution 2% can impact symptoms of ejaculatory dysfunction in men with low testosterone.

Timeline

Start
2011-08
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 60 mg Topical